Cargando…
Barrier‐forming, drug‐free nasal spray reduces allergic symptoms induced by house dust mite allergen
BACKGROUND: House Dust Mite (HDM) is the most common indoor allergen triggering allergic symptoms. First‐line pharmacotherapy treatment is recommended in international guidelines, while the avoidance of allergens represents a still unmet guideline principle. AM‐301 is a new non‐pharmacological nasal...
Autores principales: | Couroux, Patricia, Grosse, Nicole, Salapatek, Anne Marie, Goyal, Yasmeen, Pfaar, Oliver, Hohenfeld, Ilja P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345461/ https://www.ncbi.nlm.nih.gov/pubmed/37488728 http://dx.doi.org/10.1002/clt2.12277 |
Ejemplares similares
-
Efficacy and Safety of a Drug-Free, Barrier-Forming Nasal Spray for Allergic Rhinitis: Randomized, Open-Label, Crossover Noninferiority Trial
por: Nehrig, Julian, et al.
Publicado: (2023) -
β-Glucan exacerbates allergic airway responses to house dust mite allergen
por: Hadebe, Sabelo, et al.
Publicado: (2016) -
Protective effect of the DNA vaccine encoding the major house dust mite allergens on allergic inflammation in the murine model of house dust mite allergy
por: Kim, Nacksung, et al.
Publicado: (2006) -
Role of proteinase-activated receptor-2 in allergic sensitization to house dust mite allergens
por: Davidson, Courtney, et al.
Publicado: (2011) -
Immunoglobulin E to allergen components of house dust mite in Korean children with allergic disease
por: Kim, Hwan Soo, et al.
Publicado: (2015)